
Supernus Pharmaceuticals (SUPN) has had the highest return since July 31, 2011 by a US stock with a market cap of $2,013+, returning 14,519,900%.
| ASSET | % RETURN |
|---|---|
Supernus Pharmaceuticals (SUPN) | 14,519,900% |
Travere Therapeutics (TVTX) | 4,258,233.33% |
Avita Medical (RCEL) | 3,942,400% |
QXO (QXO) | 1,388,650% |
Cementos Pacasmayo SAA ADR (CPAC) | 642,900% |
Aurinia Pharmaceuticals (AUPH) | 530,934.48% |
Altimmune (ALT) | 382,400% |
Integra Resources (ITRG) | 343,900% |
Lexaria Bioscience (LEXX) | 321,438.46% |
Addex Therapeutics (ADXN) | 194,344.44% |
A2Z Smart Technologies (AZ) | 140,170.27% |
Immatics (IMTX) | 125,700% |
Fubotv (FUBO) | 114,400% |
InnovAge (INNV) | 65,774.13% |
Jade Biosciences (JBIO) | 59,130.77% |
LiveOne (LVO) | 54,100% |
Xpel (XPEL) | 52,757.14% |
NVIDIA (NVDA) | 47,955.64% |
Xcel Brands (XELB) | 30,750% |
FingerMotion (FNGR) | 29,400% |
Celsius (CELH) | 29,122.12% |
Riot Platforms (RIOT) | 27,049.68% |
Akari Therapeutics (AKTX) | 22,700% |
Tesla (TSLA) | 19,787.51% |
Patrick Industries (PATK) | 14,406.15% |